Health Care: Drugs

Mylan NV (MYL: NASDAQ)

$72.89 -0.16 | -0.22%
05/05/15 - 04:14 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 7.72B 6.91B 6.80B 6.13B
Cost of Sales 3.62B 3.35B 3.34B 3.06B
Gross Operating Profit 4.09B 3.56B 3.45B 3.07B
Selling, General, and Administrative Expenses 1.63B 1.41B 1.40B 1.21B
Research & Development 581.80M 507.82M 401.34M 294.73M
Operating Income before D & A (EBITDA) 1.89B 1.64B 1.65B 1.56B
Depreciation & Amortization 566.60M 516.00M 546.60M 510.69M
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net -44.90M -74.85M 6.56M -14.87M
Special Income / Charges 32.10M 14.64M 0.00 -48.56M
Total Income Before Interest Expenses (EBIT) 1.31B 1.06B 1.11B 990.58M
Interest Expense 333.20M 313.34M 308.70M 335.94M
Pre-Tax Income 974.50M 747.34M 804.08M 654.64M
Income Taxes 41.40M 120.81M 161.14M 115.83M
Minority Interest 3.70M 2.82M 2.08M 1.99M
Net Income From Continuing Operations 933.10M 626.53M 642.93M 538.80M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 933.10M 626.53M 642.93M 538.80M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 929.40M 623.71M 640.85M 536.81M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
901.00M 611.89M 642.93M 587.36M
Preferred Dividends
Net Income Available To Common 933.10M 626.53M 642.93M 538.80M
Basic EPS from Continuing Ops. 2.49 1.63 1.54 1.25
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 2.49 1.63 1.54 1.25
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 2.49 1.63 1.54 1.25
Basic Normalized Net Income/Share 2.40 1.59 1.54 1.36
EPS fr Continuing Ops. 2.34 1.58 1.52 1.22
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 2.34 1.58 1.52 1.22
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 2.34 1.58 1.52 1.22
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.25 1.54 1.52 1.33
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with MYL

Latest MYL Headlines from TheStreet

More Financial News for MYL

Press Releases for MYL

See All Press Releases

Partner Headlines for MYL

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter